We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$4.72B
AUM Growth
+$129M
Cap. Flow
-$61M
Cap. Flow %
-1.29%
Top 10 Hldgs %
31.68%
Holding
1,068
New
22
Increased
398
Reduced
603
Closed
42

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$7.82M
2
D icon
Dominion Energy
D
+$7.55M
3
EL icon
Estee Lauder
EL
+$7.22M
4
CDW icon
CDW
CDW
+$6.93M
5
MNST icon
Monster Beverage
MNST
+$6.78M

Top Sells

Rank Stock Value
1
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$10.6M
2
AAPL icon
Apple
AAPL
+$10.3M
3
WMT icon
Walmart Inc
WMT
+$6.86M
4
RTX icon
RTX Corp
RTX
+$6.78M
5
IBM icon
IBM
IBM
+$6.07M

Sector Composition

Rank Sector Weight
1 Technology 29.87%
2 Consumer Discretionary 13.88%
3 Healthcare 13.22%
4 Financials 11.48%
5 Communication Services 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPAY icon
226
Corpay
CPAY
$26.5B
$3.26M 0.07%
12,151
-59
-0.5% -$16K
MTCH icon
227
Match Group
MTCH
$9.46B
$3.22M 0.07%
23,443
+107
+0.5% +$16.1K
PANW icon
228
Palo Alto Networks
PANW
$312B
$3.2M 0.07%
59,610
+1,926
+3% +$114K
PNC icon
229
PNC Financial Services
PNC
$97.1B
$3.19M 0.07%
18,168
-155
-0.8% -$25.6K
CHD icon
230
Church & Dwight Co
CHD
$24.3B
$3.17M 0.07%
36,330
-167
-0.5% -$13.9K
DUK icon
231
Duke Energy
DUK
$94.2B
$3.17M 0.07%
32,797
+803
+3% +$73.3K
BIIB icon
232
Biogen
BIIB
$32.7B
$3.16M 0.07%
11,296
-229
-2% -$61.8K
ADI icon
233
Analog Devices
ADI
$181B
$3.16M 0.07%
20,365
-195
-0.9% -$30K
CME icon
234
CME Group
CME
$101B
$3.14M 0.07%
15,370
-280
-2% -$55.1K
TSCO icon
235
Tractor Supply
TSCO
$18.1B
$3.13M 0.07%
88,335
-160
-0.2% -$5.11K
TMUS icon
236
T-Mobile US
TMUS
$191B
$3.12M 0.07%
24,932
-230
-0.9% -$29K
GM icon
237
General Motors
GM
$75.6B
$3.11M 0.07%
54,143
-800
-1% -$42.5K
CL icon
238
Colgate-Palmolive
CL
$72.5B
$3.09M 0.07%
39,173
-33,472
-46% -$2.62M
WST icon
239
West Pharmaceutical
WST
$24.4B
$3.05M 0.06%
10,809
+2
+0% +$572
CB icon
240
Chubb
CB
$131B
$3.04M 0.06%
19,238
-390
-2% -$62.8K
PTC icon
241
PTC
PTC
$17.2B
$3.02M 0.06%
21,953
+135
+0.6% +$18K
IQV icon
242
IQVIA
IQV
$43.2B
$3.02M 0.06%
15,641
-109
-0.7% -$20.5K
SEDG icon
243
SolarEdge
SEDG
$2.06B
$3.02M 0.06%
10,510
+94
+0.9% +$28.3K
BDX icon
244
Becton Dickinson
BDX
$51.2B
$3.02M 0.06%
12,715
-173
-1% -$42.3K
TECH icon
245
Bio-Techne
TECH
$11.4B
$2.98M 0.06%
31,208
+396
+1% +$36.1K
TER icon
246
Teradyne
TER
$58.2B
$2.98M 0.06%
24,469
-47,713
-66% -$5.99M
CGNX icon
247
Cognex
CGNX
$10.6B
$2.97M 0.06%
35,805
+146
+0.4% +$12.2K
FDX icon
248
FedEx
FDX
$78.4B
$2.96M 0.06%
10,433
-75
-0.7% -$19.3K
FICO icon
249
Fair Isaac
FICO
$25B
$2.9M 0.06%
5,971
-3
-0.1% -$1.43K
NSC icon
250
Norfolk Southern
NSC
$78.1B
$2.9M 0.06%
10,789
-224
-2% -$56.7K

Similar funds

Xponance's Q1 2021 Portfolio in Review

As of Q1 2021, Xponance held 1,068 positions worth $4.72B, up 2.8% from $4.59B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Xponance's Q1 2021 filing shows 22 new, 398 increased, 603 reduced and 42 closed positions. Its largest new stake was NXP Semiconductors: 11,727 shares worth $2.36M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $10.6M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q1 2021 buy was NXP Semiconductors: 11,727 shares worth $2.36M.
  • Xponance added most to Visa in Q1 2021, an estimated $7.82M increase.
  • Xponance's biggest Q1 2021 reduction was Apple, cutting an estimated $10.3M.
  • Xponance fully exited iShares Core MSCI Emerging Markets ETF in Q1 2021, selling an estimated $10.6M.
  • Xponance's ten largest holdings make up 32% of its $4.72B portfolio in Q1 2021.
  • Xponance opened 22 new positions and closed 42 in Q1 2021.
  • Xponance's portfolio value rose 2.8% quarter-over-quarter to $4.72B.

Based on Xponance's 13F filing for Q1 2021, filed 10 May 2021.